Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
SQZ Biotech
company
About
SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.
- Watertown,Massachusetts,United States
- 101 - 250
- http://sqzbiotech.com
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $150K
- Industries
- Biotechnology,Life Science,Therapeutics
- Founded date
- Jan 1, 2013
- Number Of Employee
- 101 - 250
- Operating Status
- Active
- Stock Symbol
- nyse:SQZ
- Legal Name
- SQZ Biotechnologies Company
- Also Known As
- SQZ Biotechnologies
SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that develops cellular therapies for multiple indications using the proprietary CellSqueeze technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
14
$310.99M
SQZ Biotech has raised a total of
$310.99M
in funding over 2 rounds. Their latest funding was raised on
Mar 21, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 21, 2022 | Grant | $2M | 1 |
National Institute of General Medical Science
|
— | Detail |
| Feb 12, 2021 | Post-IPO Equity | $60M | — | — | — | Detail |
| Oct 29, 2020 | IPO | $81.17M | — | — | — | Detail |
| May 18, 2020 | Series D | $65M | 7 |
Temasek Holdings
|
— | Detail |
| Dec 18, 2019 | Series D | — | 4 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
8
21
SQZ Biotech is funded by 21 investors.
National Institute of General Medical Science
and Temasek Holdings
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institute of General Medical Science
|
Yes | Grant |
|
Temasek Holdings
|
Yes | Series D |
National Science Foundation
|
Yes | Grant |
GV
|
— | Series D |
Illumina Ventures
|
— | Series D |
Invus
|
— | Series D |
JDRF T1D Fund
|
— | Series D |
NanoDimension
|
— | Series D |
Polaris Partners
|
— | Series D |
Alumni Ventures
|
— | Series D |
Employee Profiles
Number of Employee Profiles
17
SQZ Biotech has 17 current employee profiles, including
Executive Howard Bernstein
Executive
Executive
Executive
Employee
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
